Scarica l'app Stockscreener
1.31
0.00%
0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vivani Medical Inc Borsa (VANI) Ultime notizie
Vivani Medical Partners with Novo Nordisk to Evaluate Ultra Long-Acting Semaglutide Implant for Weight Management - Minichart
Vivani in pact with Novo to study Wegovy implant (NVO:NYSE) - Seeking Alpha
Novo Nordisk to evaluate Vivani Medical's semaglutide implant - marketscreener.com
Vivani Advances GLP-1 Implant Program With Novo Nordisk - TipRanks
Vivani Medical Says Novo Nordisk to Evaluate Semaglutide Implant for Weight Management - marketscreener.com
Vivani Medical to Merge Cortigent Into ClearOne; Receives 12.5M Shares, Deal Needs $10–15M Financing - TradingView
Novo Nordisk will evaluate Vivani’s semaglutide implant for weight loss - Stock Titan
ClearOne to Acquire Cortigent, Inc. in Major Merger with Vivani Medical Subsidiary, Paving Way for Precision Neurostimulation Advances 1 – Minichart - Minichart
ClearOne (Nasdaq: CLRO) sets Cortigent merger, Vivani majority stake and $10–15M raise - Stock Titan
Vivani strikes reverse-merger agreement with ClearOne for BCI business - Yahoo Finance
We're Keeping An Eye On Vivani Medical's (NASDAQ:VANI) Cash Burn Rate - Sahm
ClearOne (CLRO) to Acquire Vivani Medical's Cortigent in Strategic Merger - GuruFocus
Why Did CLRO Stock Surge More Than 170% Today? - TradingView
ClearOne agrees merger to acquire Cortigent - grafa.com
Vivani to sell neurotech subsidiary Cortigent to ClearOne - MassDevice
ClearOne to acquire Cortigent in reverse merger transaction By Investing.com - Investing.com South Africa
ClearOne to acquire Cortigent in reverse merger transaction - Investing.com UK
Lake Street Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Vivani to merge Cortigent unit with ClearOne in $10-15M deal - Investing.com South Africa
Clearone Announces Entry Into Merger Agreement With Cortigent, Inc., A Wholly-Owned Subsidiary Of Vivani Medical - TradingView
Vivani Announces Entry into Merger Agreement Between Wholly - GlobeNewswire
Price to earnings forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical Advances SLIM-1 Trial for Obesity Treatment - TipRanks
Form 4 Vivani Medical Inc For: 26 June By Investing.com - Investing.com South Africa
Enterprise value to EBIT forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Enterprise value to EBIT forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical Inc. Actuals & Estimates (NASDAQ:VANI) - TradingView
Price to book forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Price to book forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical appoints August Moretti to board of directors By Investing.com - Investing.com Australia
Vivani’s Board Overhaul Signals High-Stakes Push into GLP-1 Market - BriefGlance
Vivani Medical appoints August Moretti to board of directors - Investing.com
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker - GlobeNewswire
Price to sales forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Form 4 Vivani Medical Inc For: 25 June By Investing.com - Investing.com Australia
Price to sales forward of Vivani Medical Inc. – DUS:U5P - TradingView
Enterprise value to EBITDA forward of Vivani Medical Inc. – DUS:U5P - TradingView
Price to earnings forward of Vivani Medical Inc. – DUS:U5P - TradingView
Enterprise value to revenue forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical receives approval to start semaglutide implant trial - Investing.com
Vivani Medical (VANI) Secures Approval for Phase 1 Clinical Tria - GuruFocus
Vivani Medical receives approval to start semaglutide implant trial By Investing.com - Investing.com Australia
Vivani Medical Receives Regulatory Approval to Test Potential Weight Loss Drug Implant - marketscreener.com
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management - GlobeNewswire
Vivani Medical Inc (VANI) Institutional Confidence - TradingKey
Vivani Medical Price Target Announced at $4.00/Share by Lake Street - Moomoo
Lake Street Initiates Coverage on Vivani Medical With Buy Rating, $4 Price Target - Moomoo
Lake Street initiates Vivani Medical stock with buy on implant tech - Investing.com South Africa
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention - GlobeNewswire
Vivani Medical Inc (VANI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VANI Q1 2026 Earnings: Narrower-Than-Expected Loss as Vivani Advances Preclinical PipelineProfit Cycle Analysis - dars.gov.et
Vivani Medical Inc (VANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivani Medical Inc (VANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vivani Medical Inc (VANI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vivani Medical Inc (VANI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vivani Medical Inc (VANI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
1.26%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):